IASLC WCLC 2018: IMpower132 Study Showcases Efficacy and Safety of Atezolizumab for Stage IV Non-Squamous NSCLC
Latest interim analysis reveals superior progression-free survival and hints at overall survival benefits with the addition of atezolizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.